Moderna stock has fallen over the past four years, but shares got a boost on positive comments about AI. Is MRNA stock a buy ...

We recently compiled a list of the These 10 Companies Led Gains on Wednesday. In this article, we are going to take a look at ...

From groundbreaking immunotherapies to advanced targeted treatments, oncology is set to make historic strides in the year ...

Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...

The U.S. Department of Health and Human Services or HHS said it will provide approximately $590 million to Moderna (MRNA) to ...

Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.

Moderna’s mRNA-1403 is a messenger RNA-based trivalent vaccine candidate designed to protect against multiple norovirus genotypes. Moderna provided an update on the status of its trial investigating a ...

What happened to the need to end commuting and presenteeism? Or to our gratitude for healthcare workers or our resolution to ...

In a report released today, Tim Anderson from Bank of America Securities maintained a Sell rating on Moderna (MRNA – Research Report), with a ...

The announcement comes as Moderna charts a path forward after the rapid decline in demand for its Covid vaccine. Moderna now expects 2025 revenue of between $1.5 billion and $2.5 billion, most of ...

Copyright 2025 The Associated Press. All Rights Reserved. A local resident receives the Moderna COVID-19 vaccine shot at a ...

Up to 21 million people contract norovirus each year in the U.S. alone, the CDC says. Though most people recover from the ...